- Home
- GIC vs JANX Comparison
GIC vs JANX Comparison
Compare GIC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIC
- JANX
- Stock Information
- Founded
- GIC 1949
- JANX 2017
- Country
- GIC United States
- JANX United States
- Employees
- GIC N/A
- JANX N/A
- Industry
- GIC Industrial Machinery/Components
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- GIC Industrials
- JANX Health Care
- Exchange
- GIC Nasdaq
- JANX Nasdaq
- Market Cap
- GIC 1.4B
- JANX 1.4B
- IPO Year
- GIC 1995
- JANX 2021
- Fundamental
- Price
- GIC $34.94
- JANX $24.05
- Analyst Decision
- GIC
- JANX Strong Buy
- Analyst Count
- GIC 0
- JANX 11
- Target Price
- GIC N/A
- JANX $76.55
- AVG Volume (30 Days)
- GIC 92.3K
- JANX 790.8K
- Earning Date
- GIC 10-28-2025
- JANX 11-05-2025
- Dividend Yield
- GIC 3.00%
- JANX N/A
- EPS Growth
- GIC N/A
- JANX N/A
- EPS
- GIC 1.71
- JANX N/A
- Revenue
- GIC $1,324,600,000.00
- JANX $439,000.00
- Revenue This Year
- GIC $5.10
- JANX N/A
- Revenue Next Year
- GIC $3.40
- JANX $130.50
- P/E Ratio
- GIC $20.41
- JANX N/A
- Revenue Growth
- GIC N/A
- JANX N/A
- 52 Week Low
- GIC $20.79
- JANX $21.73
- 52 Week High
- GIC $38.79
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- GIC 37.93
- JANX 46.31
- Support Level
- GIC $35.25
- JANX $22.23
- Resistance Level
- GIC $36.37
- JANX $24.57
- Average True Range (ATR)
- GIC 0.80
- JANX 1.20
- MACD
- GIC -0.37
- JANX -0.03
- Stochastic Oscillator
- GIC 4.24
- JANX 31.49
About GIC Global Industrial Company
Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.